The enzyme-linked immunosorbent assay (ELISA) testing market will witness a neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio’s ...
COVID-19 has thrown ELISA testing into the spotlight and driven advances in technology allowing the process to become quicker and more accurate. While there are limits to ELISA antibody tests’ ...
To ensure safer blood transfusions, the government has mandated the use of ELISA tests for infectious disease screening in blood centres. This regulation follows HIV cases linked to contaminated blood ...